Edesa Biotech, Inc. (EDSA)
Largest Insider Buys in Sector
EDSA Stock Price History Chart
EDSA Stock Performance
About Edesa Biotech, Inc.
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal …
Insider Activity of Edesa Biotech, Inc.
Over the last 12 months, insiders at Edesa Biotech, Inc. have bought $20,000 and sold $0 worth of Edesa Biotech, Inc. stock.
On average, over the past 5 years, insiders at Edesa Biotech, Inc. have bought $316,877 and sold $416,206 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Nijhawan Pardeep (Chief Executive Officer) — $20,000.
The last purchase of 5,000 shares for transaction amount of $20,000 was made by Nijhawan Pardeep (Chief Executive Officer) on 2024‑03‑25.
List of Insider Buy and Sell Transactions, Edesa Biotech, Inc.
| 2024-03-25 | Chief Executive Officer | 5,000 0.1509% | $4.00 | $20,000 | +4.43% | |||
| 2023-01-10 | Sale | director | 152,345 0.8038% | $2.63 | $401,368 | -30.36% | ||
| 2023-01-09 | Sale | director | 145,129 0.7355% | $2.66 | $386,348 | -30.36% | ||
| 2022-06-30 | Chief Executive Officer | 20,000 0.165% | $1.60 | $32,078 | -29.19% | |||
| 2022-06-29 | President | 3,000 0.0196% | $1.49 | $4,483 | -22.30% | |||
| 2022-06-16 | President | 3,000 0.0189% | $1.61 | $4,817 | -24.24% | |||
| 2022-05-27 | Chief Executive Officer | 5,000 0.0317% | $1.92 | $9,599 | -28.57% | |||
| 2022-05-25 | President | 3,500 0.0226% | $1.74 | $6,090 | -19.54% | |||
| 2022-05-24 | Chief Executive Officer | 2,000 0.0133% | $1.80 | $3,600 | -19.43% | |||
| 2022-03-31 | Chief Executive Officer | 2,000 0.013% | $2.99 | $5,972 | -45.45% | |||
| 2022-03-30 | Chief Executive Officer | 2,000 0.0148% | $3.05 | $6,098 | -45.30% | |||
| 2022-03-29 | Chief Executive Officer | 2,000 0.0147% | $3.02 | $6,034 | -44.75% | |||
| 2022-03-18 | Chief Executive Officer | 2,000 0.0138% | $3.85 | $7,699 | -58.48% | |||
| 2022-03-17 | Chief Executive Officer | 397 0.0027% | $3.25 | $1,290 | -50.74% | |||
| 2022-03-15 | Chief Executive Officer | 2,000 0.0131% | $2.80 | $5,598 | -45.63% | |||
| 2022-03-14 | President | 1,250 0.0092% | $2.79 | $3,487 | -37.87% | |||
| 2022-03-11 | Chief Executive Officer | 5,000 0.0368% | $3.06 | $15,295 | -43.67% | |||
| 2022-03-10 | President | 1,000 0.0074% | $3.22 | $3,223 | -46.35% | |||
| 2022-03-09 | Chief Executive Officer | 1,500 0.0103% | $3.05 | $4,570 | -46.71% | |||
| 2022-03-08 | President | 1,250 0.0091% | $2.90 | $3,622 | -40.56% |